170 related articles for article (PubMed ID: 12483968)
1. Phenolic glycolipid-1 (PGL-1) in Buruli ulcer lesions. First demonstration by immuno-histochemistry.
Mwanatambwe M; Yajima M; Etuaful S; Fukunishi Y; Suzuki K; Asiedu K; Yamada N; Asanao G
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):201-5. PubMed ID: 12483968
[TBL] [Abstract][Full Text] [Related]
2. High rates of apoptosis in human Mycobacterium ulcerans culture-positive buruli ulcer skin lesions.
Walsh DS; Meyers WM; Portaels F; Lane JE; Mongkolsirichaikul D; Hussem K; Gosi P; Myint KS
Am J Trop Med Hyg; 2005 Aug; 73(2):410-5. PubMed ID: 16103613
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium ulcerans infection (Buruli ulcer): a case report of the disseminated nonulcerative form.
Abalos FM; Aguiar J; Guédénon A; Portaels F; Meyers WM
Ann Diagn Pathol; 2000 Dec; 4(6):386-90. PubMed ID: 11149971
[TBL] [Abstract][Full Text] [Related]
4. Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans.
Yeboah-Manu D; Peduzzi E; Mensah-Quainoo E; Asante-Poku A; Ofori-Adjei D; Pluschke G; Daubenberger CA
J Leukoc Biol; 2006 Jun; 79(6):1150-6. PubMed ID: 16531561
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection).
Walsh DS; Portaels F; Meyers WM
Curr Opin Infect Dis; 2010 Oct; 23(5):445-55. PubMed ID: 20581668
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
[TBL] [Abstract][Full Text] [Related]
7. Contiguous spread of Mycobacterium ulcerans in Buruli ulcer lesions analysed by histopathology and real-time PCR quantification of mycobacterial DNA.
Rondini S; Horsfield C; Mensah-Quainoo E; Junghanss T; Lucas S; Pluschke G
J Pathol; 2006 Jan; 208(1):119-28. PubMed ID: 16261539
[TBL] [Abstract][Full Text] [Related]
8. Early trafficking events of Mycobacterium ulcerans within Naucoris cimicoides.
Marsollier L; André JP; Frigui W; Reysset G; Milon G; Carbonnelle B; Aubry J; Cole ST
Cell Microbiol; 2007 Feb; 9(2):347-55. PubMed ID: 16939536
[TBL] [Abstract][Full Text] [Related]
9. Buruli ulcer (Mycobacterium ulcerans infection).
Walsh DS; Portaels F; Meyers WM
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
[TBL] [Abstract][Full Text] [Related]
10. Clinical and histologic features of skin lesions in a cynomolgus monkey experimentally infected with mycobacterium ulcerans (Buruli ulcer) by intradermal inoculation.
Walsh DS; Dela Cruz EC; Abalos RM; Tan EV; Walsh GP; Portaels F; Meyers WM
Am J Trop Med Hyg; 2007 Jan; 76(1):132-4. PubMed ID: 17255241
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
Nakanaga K; Saito H; Ishii N; Goto M
Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
[TBL] [Abstract][Full Text] [Related]
12. [Facial localizations of Buruli ulcers: two cases].
Ouattara D; Aka GK; Meningaud JP; Sica A; Kaba L; Gadegbeku S
Rev Stomatol Chir Maxillofac; 2003 Sep; 104(4):231-4. PubMed ID: 14631235
[TBL] [Abstract][Full Text] [Related]
13. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
Walsh DS; Portaels F; Meyers WM
Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
[TBL] [Abstract][Full Text] [Related]
14. [Mycobacterium ulcerans infection].
Dega H; Chosidow O; Barete S; Carbonnelle B; Grosset J; Jarlier V
Ann Med Interne (Paris); 2000 Sep; 151(5):339-44. PubMed ID: 11033467
[TBL] [Abstract][Full Text] [Related]
15. Buruli ulcer and schistosomiasis: no association found.
Stienstra Y; van der Werf TS; van der Graaf WT; Secor WE; Kihlstrom SL; Dobos KM; Asamoa K; Quarshi E; Etuaful SN; Klutse EY; King CH
Am J Trop Med Hyg; 2004 Sep; 71(3):318-21. PubMed ID: 15381813
[TBL] [Abstract][Full Text] [Related]
16. Prospects for vaccine development against Buruli disease.
Huygen K
Expert Rev Vaccines; 2003 Aug; 2(4):561-9. PubMed ID: 14711340
[TBL] [Abstract][Full Text] [Related]
17. [Contribution of gene amplification in Mycobacterium ulcerans detection in exudates and cutaneous biopsies in Côte d'Ivoire].
Ekaza E; Kacou-N'Douba A; Oniangué NC; Ehuie P; N'guessan KR; Aka N; Bouzid SA; Faye-Ketté H; Dosso M
Bull Soc Pathol Exot; 2004 May; 97(2):95-6. PubMed ID: 15255348
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
[TBL] [Abstract][Full Text] [Related]
19. [Buruli ulcer (Mycobacterium ulcerans infection); report from the International Congress in Yamoussoukro, Ivory Coast].
van der Graaf WT; Scherpbier RW; van der Werf TS
Ned Tijdschr Geneeskd; 1999 Feb; 143(6):312-6. PubMed ID: 10221089
[TBL] [Abstract][Full Text] [Related]
20. Distribution of Buruli ulcer lesions over body surface area in a large case series in Ghana: uncovering clues for mode of transmission.
Hospers IC; Wiersma IC; Dijkstra PU; Stienstra Y; Etuaful S; Ampadu EO; van der Graaf WT; van der Werf TS
Trans R Soc Trop Med Hyg; 2005 Mar; 99(3):196-201. PubMed ID: 15653121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
